Table 2. Characteristics of investigated tests and reference standard used in selected studies.
Authors | Lytwyn et al.,17 2000 | ALTS Group,7 2003 | Andersson et al.,18 2005 |
---|---|---|---|
Repeated cytological test: | |||
Technique | Conventional | Liquid-based ThinPrep* | Conventional |
Nomenclature | Bethesda, 1991 | Bethesda, 1991 | Bethesda, 1991 |
Colposcopic referral threshold | ASCUS, HSIL | HSIL | Any abnormality |
HPV-DNA test: | |||
Technique | HC2 | HC2 | HC2 |
Positivity cutoff | 1 pg/ml | 1 pg/ml | 1 pg/ml |
Reference standard |
|
|
|
*Cytyc Corporation, Boxborough, Massachusetts, United States; ASCUS = Atypical Squamous Cells of Undetermined Significance; HSIL = High Grade Squamous Intraepithelial Lesions; HC2 = Hybrid Capture-2 (Qiagen Gaithersburg, Inc. Maryland, United States, previously Digene Corporation); LEEP = Loop electrosurgical excision procedure, including large loop excision of the transformation zone (LLETZ) or conization.